About Jill Davies
Form D filings for Genome Medical Holding in 2024 list Jill Davies as chief executive officer and director.
Jill Davies first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jill Davies in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jill Davies works with at each company, as listed on that company's latest Form D.
Genome Medical Holding Co · Form D, Sep 23, 2024
SR
Shaun Rodriguez
Director
EM
Elizabeth Moreno
Executive officer
AP
Alex Parker
Director
MS
Mark Sylvester
Executive officer
RG
Russell Glass
Director